FDA Brief

Company record

Samm Solutions, Inc., d.b.a. BTS Research

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Samm Solutions, Inc., d.b.a. BTS Research.

Warning letters

  1. Samm Solutions, Inc., d.b.a. BTS Research

    Samm Solutions/BTS Research failed good laboratory practice (GLP) rules for nonclinical drug studies, FDA says.

    Medium